InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.145

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$74 Change of Director's Interest Notice - Jane Bell 10 Feb 2022 1:08PM $0.170 $0.145 fallen by 14.71%
$74 Amplia Investor Presentation - February 2022 1 Feb 2022 8:21AM $0.160 $0.145 fallen by 9.38%
$74 Quarterly Activities and Cashflow Reports - Dec 2021 Qtr 24 Jan 2022 8:13AM $0.165 $0.145 fallen by 12.12%
$74 Notification regarding unquoted securities - ATX 19 Jan 2022 9:03AM $0.170 $0.145 fallen by 14.71%
$74 Amplia Completes Manufacture of AMP945 for Planned Trials 13 Jan 2022 9:45AM $0.160 $0.145 fallen by 9.38%
$74 Change in substantial holding 23 Dec 2021 4:29PM $0.165 $0.145 fallen by 12.12%
$74 Application for quotation of securities - ATX 22 Dec 2021 2:28PM $0.170 $0.145 fallen by 14.71%
$74 Application for quotation of securities - ATX 22 Dec 2021 11:42AM $0.170 $0.145 fallen by 14.71%
$74 Change in substantial holding 22 Dec 2021 9:24AM $0.155 $0.145 fallen by 6.45%
$74 App 3Y - Change of Director's Interest - Mrs Jane Bell 21 Dec 2021 3:13PM $0.153 $0.145 fallen by 4.92%
$74 App 3Y - Change of Director's Interest - Dr. Chris Burns 21 Dec 2021 3:13PM $0.153 $0.145 fallen by 4.92%
$74 App 3Y - Change of Director's Interest - Dr. Robert Peach 21 Dec 2021 3:10PM $0.153 $0.145 fallen by 4.92%
$74 App 3Y - Change of Director's Interest - Dr. John Lambert 21 Dec 2021 3:09PM $0.153 $0.145 fallen by 4.92%
$74 App 3Y - Change of Directors Interest Notice - Dr. W. Tong 21 Dec 2021 3:07PM $0.153 $0.145 fallen by 4.92%
$74 Proposed issue of securities - ATX 21 Dec 2021 11:40AM $0.160 $0.145 fallen by 9.38%
$74 Update - Application for quotation of securities - ATX 20 Dec 2021 8:33AM $0.155 $0.145 fallen by 6.45%
$74 Results of Extraordinary General Meeting 17 Dec 2021 2:29PM $0.160 $0.145 fallen by 9.38%
$74 Amplia Provides Updated Investor Presentation 16 Dec 2021 9:52AM $0.170 $0.145 fallen by 14.71%
$74 Change in substantial holding 15 Dec 2021 1:38PM $0.170 $0.145 fallen by 14.71%
$74 Update - Application for quotation of securities - ATX 15 Dec 2021 10:42AM $0.175 $0.145 fallen by 17.14%
$74 Update - Proposed issue of securities - ATX 14 Dec 2021 9:53AM $0.170 $0.145 fallen by 14.71%
$74 Entitlement Offer Completed 10 Dec 2021 11:26AM $0.170 $0.145 fallen by 14.71%
$74 Amplia Awarded $2.1M R&D Cash Flow Loan 2 Dec 2021 11:10AM $0.170 $0.145 fallen by 14.71%
$74 App 4D and Financial Report Half Year ended 30 Sep 2021 24 Nov 2021 4:45PM $0.190 $0.145 fallen by 23.68%
$74 Notice of Extraordinary General Meeting - 17 Dec 2021 19 Nov 2021 10:21AM $0.210 $0.145 fallen by 30.95%

301 - 325 of 538 results

Page 13 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.